Purchase Order W81K0024P0230
Award Date
10/1/24
Potential Completion Date
9/30/25
Potential Value
$420K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Boston Scientific Corp
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command intends to award a firm fixed price sole source contract to Boston Scientific Corporation in the amount of $658,800. The contract is pursuant to Federal Acquisition Regulation 13.501(a)(1)(ii) for the delivery of TheraSphere, Boston Scientific's FDA-approved therapy utilizing yttrium-90 radioactive microspheres to treat primary liver cancer. Per the pre-solicitation notice, TheraSphere is the only approved treatment for this indication. The contract...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a sole source purchase order contract to Boston Scientific Corp, doing business as Boston Scientific, to provide a 12-month supply of Therasphere Yttrium-90 (Y-90) radiopharmaceutical doses. The $143,960.00 firm fixed price contract will support the Dayton VA Medical Center's Nuclear Medicine Department in treating hepatocellular carcinoma. As the exclusive manufacturer of Therasphere, Boston Scientific was...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Boston Scientific Corp for the supply of radiopharmaceutical therapy/treatment for liver cancer and hepatocellular carcinoma (HCC) containing the radioactive isotope yttrium-90. The contract, valued at $573,155.00, is for the delivery of an estimated 36 units over a one-year period on an as-needed basis. This requirement was not set aside for small businesses....
The Department of the Army Medical Command awarded a $639,000 firm fixed price purchase order to Boston Scientific Corporation for TheraSphere doses. TheraSphere is an FDA-approved radioactive microsphere therapy used to treat primary liver cancer. The solicitation indicated intent to make a sole source award to Boston Scientific under FAR 13.501(a)(1)(ii) for supplying TheraSphere to treat patients at Regional Health Command Central medical facilities. Interested parties were provided until...
This is a federal contract award from the Department of Veterans Affairs (VA) to Boston Scientific Corp, a medical technology company based in Marlborough, Massachusetts. The contract, valued at $165,105.00, is for the delivery of TheraSphere Y-90 radioactive microspheres, a specialized medical product used in the treatment of liver cancer. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on September 30, 2025. Boston Scientific, as the prime contractor, will...
The U.S. Department of Veterans Affairs (VA) has awarded a sole-source, firm-fixed-price contract to Boston Scientific Corp for the supply of Y-90 TheraSphere doses and associated administration materials. The contract, valued at $777,740.00, covers an initial 2-year base period from October 1, 2022, to September 30, 2024, with an option to extend for an additional year through September 30, 2024. This contract is not set-aside. The Y-90 TheraSphere doses are used for the treatment of liver...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Boston Scientific Corp. for the provision of Yttrium-90 TheraSpheres, a radioactive microsphere treatment for primary liver cancer. The contract has a ceiling value of $1,668,770.00 and a period of performance ending on March 31, 2026. The original solicitation was a pre-solicitation notice seeking market research for a potential 5-year blanket purchase agreement (BPA) to supply Yttrium-90...
This is a $196,300.00 firm-fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract, which does not have a set-aside designation, is for the delivery of Y90 products. Boston Scientific has received multiple contract and grant awards from federal agencies, including the VA, Defense Health Agency, and National Institutes of Health, to provide specialized medical technologies and...
The U.S. Department of Veterans Affairs (VA) awarded a $4,643,080 firm-fixed-price purchase order contract to Boston Scientific Corp, a leading manufacturer of medical devices, for the delivery of Y90 glass microspheres. This contract, which does not have a set-aside designation, has an ultimate completion date of April 22, 2027. Boston Scientific is also the holder of several indefinite delivery/indefinite quantity (IDIQ) contracts with the VA, including a $295 million IDIQ for surgical...
Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $313,200 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide Yttrium-90 TheraSphere radioactive microspheres. This delivery order was issued against the company's existing indefinite delivery contract with the VA worth up to $295 million over five years to supply surgical implants and related services. No set-aside...